# ProjectKnight Studio V3 — Production Status

Updated: 2026-11-05
Working branch: `studio/v3-002-agent-orchestrator-r2`
R2 start baseline: `67e60384c920c03e9b7d9dc730bd939a56b77f21`

## Current status
- Previous production systems: RETIRED. No historical QA score or PASS is authoritative.
- Game runtime and assets: PRESERVED; R2 is restricted to Studio orchestration infrastructure.
- Six role definitions and native Antigravity subagent session transcripts: PRESENT from R1.
- Five reported live native-subagent session records and repaired health fixture: PRESENT (R1).
- **Single Producer entrypoint controlling actual subagents end to end:** NOT VERIFIED.
- **Provider-authenticated, role-bound independent two-key approval:** NOT VERIFIED; R1 independent review identified forgery risk.
- **Reviewer verdict based on semantic QA results rather than process success:** R1 BLOCKER, not fixed yet.
- Existing 20/20 test PASS: reported by implementation; not independently rerun.
- Actual in-game visual QA and Android performance: NOT VERIFIED.
- Movement plane X/Y vs X/Z: UNDECIDED; part of V3-001.

## Tasks
- `V3-001` READY — baseline playable capture, gameplay-plane decision; can proceed in parallel.
- `V3-002` FIX_REQUIRED — integration infrastructure not approved.
- `V3-002-R2` READY — `STUDIO_V3/tasks/V3-002-R2.md`; priority P0.
- `V3-003` BLOCKED — Stage 1 production requires approvals on V3-001 and V3-002.

## Acceptance standard
R2 must demonstrate real Producer worker → QA reject → worker fix → QA retest → Director review from one execution entrypoint, with provider identity, final task/issue states, immutable exact Git SHA and sanitized logs.
No success claim is inferred from session creation, CLI exit code, a manual review name or mock tests. If the live runtime does not expose an authenticated completion channel, mark LIVE_AUTONOMOUS_LOOP_NOT_VERIFIED and keep V3-002 blocked.

## Review
Independent R1 findings: `STUDIO_V3/reviews/V3-002-R1-INDEPENDENT-REVIEW.md`.
R2 work specification: `STUDIO_V3/tasks/V3-002-R2.md`.
